Ticker LaunchIPO · OLMA
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. (OLMA) priced its initial public offering on Nov 19, 2020 at $19.00 per share, above its $16.00–$18.00 range, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $731.9M. Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- OLMA
- Exchange
- Nasdaq Global Select
- Priced
- Nov 19, 2020
- IPO price
- $19.00
- Price range
- $16.00–$18.00
- Market cap at IPO price
- $731.9M
- First filed
- Oct 30, 2020
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Oct 30, 2020
- Latest amendment Nov 16, 2020
- Final prospectus (424B4) Nov 19, 2020
- All filings on EDGAR CIK 1750284
Other Biotech & pharma IPOs in 2020
- Sigilon Therapeutics, Inc.SGTX · Dec 7, 2020 · $126M
- ARS Pharmaceuticals, Inc.SBTX · Dec 4, 2020 · $241.5M
- Kinnate Biopharma Inc.KNTE · Dec 3, 2020
- Maravai Lifesciences Holdings, Inc.MRVI · Nov 23, 2020 · $1.62B
- Atea Pharmaceuticals, Inc.AVIR · Oct 30, 2020 · $300M
- Damora Therapeutics, Inc.GLTO · Oct 30, 2020 · $85M